← 返回

肿瘤相关 NK 细胞通过 NKp46 在免疫健全小鼠肝细胞癌中促进肿瘤生长

英文原题:Tumor-associated NK cells facilitate tumor growth via NKp46 in immunocompetent murine hepatocellular carcinoma.

查看英文原题

Tumor-associated NK cells facilitate tumor growth via NKp46 in immunocompetent murine hepatocellular carcinoma.

PubMed 2023/04/28(内容时间) Immunol Lett Q3 · IF 3.2(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

自然杀伤(NK)细胞是固有淋巴样细胞家族的一个亚群。尽管已有报道表明 NK 细胞具有抗肿瘤活性,但其对肿瘤控制的实际贡献仍存在争议。这是由于对肿瘤微环境(TME)中 NK 细胞改变的认识尚不完整。

在此,我们利用小鼠肝细胞癌(HCC)模型显示,早期删除 NK 细胞以 CD8+ T 细胞依赖的方式显著减弱了肿瘤生长。这一效应伴随着肿瘤内而非循环血液中 CD8+ T 细胞效应功能的增强。随后,我们证明,在肿瘤进展过程中,大量 NKp46+ NK 亚群而非 NKp46- NK 被募集至肿瘤微环境。瘤内 NKp46+ NK 细胞的频率与 CD8+ T 细胞活化呈负相关,并与肿瘤生长呈正相关。与 NKp46- NK 细胞相比,瘤内 NKp46+ NK 细胞表现出功能障碍和抑制性受体表达增加。阻断 NK 细胞相关 NKp46 可有效减弱 HCC 生长。与单独接种肿瘤细胞相比,输注肿瘤来源的 NKp46+ NK 细胞在体内显著促进了 HCC 生长。

进一步的机制研究揭示,NK 细胞通过 NKp46 介导的 CD8+ T 细胞效应功能受损来促进肿瘤生长。总体而言,这项工作支持了肿瘤相关 NK 细胞在 HCC 中一种此前未被充分认识到的调节特性,并将 NKp46 作为临床环境中对抗 HCC 的潜在靶点。

展开英文摘要原文

Natural killer(NK) cells comprise one subset of the innate lymphoid cells family. Despite reported anti-tumor activity of NK cells, their tangible contribution to tumor control remains controversial. This is due to the incomplete understanding of NK alterations within tumor microenvironment(TME).

Here we showed, using murine hepatocellular carcinoma(HCC) model, that early NK cells deletion markedly attenuated tumor growth in a CD8 + T cells dependent manner. This effect was accompanied by an enhanced CD8 + T cells effector function in tumor rather than circulating blood. Then, we demonstrated that abundant NKp46 + NK subset, but not NKp46 - NK, were recruited towards tumor microenvironment during tumor progression. Frequency of intratumor NKP46 + NK cells were inversely related to CD8 + T cells activation, and positively correlated with tumor growth.

Intratumor NKp46 + NK cells exhibited dysfunction and increased expression of inhibitory receptors, when compared with NKp46 - NK cells. Blockade of NK cells-associated NKp46 effectively attenuated HCC growth. Infusion of tumor-derived NKp46 + NK cells markedly enhanced HCC growth in vivo, in contrast to tumor cells inoculation alone. The further mechanistic investigations unveiled that NK cells boosted tumor growth by NKp46-mediated impairment of CD8 + T cells effector function.

Overall, this work supported a previously unappreciated regulatory property of tumor-associated NK cells in HCC, and NKp46 as a potential target against HCC in clinical setting.

论文信息

作者
Guan X、Lu Y、Zhang Y、Zhan P、Chen Z、Wang C、Yin Z
第一作者单位
Xiamen Translational Medical Key Laboratory of Digestive System Tumor, Fujian Provincial Key Laboratory of Chronic Liver Disease and Hepatocellular Carcinoma, School of Medicine, Zhongshan Hospital of Xiamen University, Xiamen University, Xiamen, China; Department of Clinical Laboratory, The First Affiliated Hospital of USTC, University of Science and Technology of China, Hefei, Anhui, China.China
通讯作者单位
Department of Hepatobiliary Surgery, Xiamen Hospital of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Xiamen, China; Xiamen Translational Medical Key Laboratory of Digestive System Tumor, Fujian Provincial Key Laboratory of Chronic Liver Disease and Hepatocellular Carcinoma, School of Medicine, Zhongshan Hospital of Xiamen University, Xiamen University, Xiamen, China. Electronic address: 18133637730m@sina.cn.China
期刊
Immunology letters2023 Jun
原文标识
PubMed 37121554 · DOI 10.1016/j.imlet.2023.04.009